Show source-provided references
2. Universal screening for infant hearing impair-ment. European concerted action on otoacoustic emissions
5. Efficacy of a community-based infant hearing screening program utilizing existing clinic personnel in Western Cape, South Africa
10.1016/j.ijporl.2012.01.015 ↗8. Comparisons of transient evoked otoacoustic emissions using chirp and click stimuli
10.1121/1.4962532 ↗9. Audiologic and vestibular assessment in patients with β-thalassemia major receiving long-term transfusion therapy
10.1002/pbc.24699 ↗10. Measuring distortion product otoacoustic emissions using continuously sweeping primaries
10.1121/1.2949505 ↗13. Compensating for ear-canal acoustics when measuring otoacoustic emissions
10.1121/1.4973618 ↗15. Original article: Comparison of two methods of TEOAE recording in newborn hearing screening: La comparación de dos métodos de registro de TEOAE en la identificatión de problemas auditivos en recién nacidos
10.3109/14992020209077185 ↗16. Normative data for five FDA-approved distortion product OAE system
18. Similarities and differences in distortion-product otoacoustic emissions among four FDA-approved devices
10.1055/s-0042-1745626 ↗19. Neonatal newborn hearing screening: Four years’ experience at Ferrara University Hospital (CHEAP Project): Part 1
25. Detection of Age-Related Hearing Losses (ARHL) via transient-evoked otoacoustic emissions
10.2147/CIA.S252837 ↗26. Time–frequency analysis of click-evoked otoacoustic emissions by means of a minimum variance spectral estimation-based method
10.1016/j.heares.2008.07.002 ↗29. Field, A. (2014). Discovering Statistics Using IBM SPSS Statistics, Sage. [4th ed.].
30. (2014, February 27). Food and Drug Administration Indication for Use 510(k), Madsen Accuscreen Type 1077, Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K132957.
31. A comparison of transient-evoked and distortion product otoacoustic emissions in normal-hearing and hearing-impaired subjects
10.1121/1.407348 ↗